Floatz logo

DEXAMETHASONE

Newly Diagnosed Patients

Fondazione EMN Italy OnlusSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Newly Diagnosed Patients cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Fondazione EMN Italy Onlus
Phase 3BB
cc-5013
Fondazione EMN Italy Onlus
Phase 3B
FILGRASTIM
Fondazione EMN Italy Onlus
Phase 3B
Evomela
Fondazione EMN Italy Onlus
Phase 3B

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →